Table 2.
Effect of RT and RP on the survival outcomes.
| HR | 95%CI | p-value | |
|---|---|---|---|
| Cancer-specific mortality | |||
| Adjusted non-matched cohort | 0.86 | 0.58–1.27 | 0.444 |
| Adjusted PSM cohort | 0.77 | 0.46–1.30 | 0.325 |
| Adjusted SMRW cohort | 0.83 | 0.53–1.32 | 0.435 |
| All-cause mortality | |||
| Adjusted non-matched cohort | 0.78 | 0.56–1.09 | 0.148 |
| Adjusted PSM cohort | 0.73 | 0.48–1.11 | 0.138 |
| Adjusted SMRW cohort | 0.75 | 0.52–1.09 | 0.132 |
RP, radical prostatectomy with or without external beam radiation therapy; RT, brachytherapy with or without external beam radiation therapy; HR, hazard ratio; CI, confidence interval; PSM, propensity score matching; SMRW, standardized mortality ratio weighting.